RJFSA
GHSI

Raymond James Financial Services Advisors’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-300
Closed -$2.18K – 3423
2022
Q4 		$2.18K Hold
300
– – ﹤0.01% 3236
2022
Q3 		$2K Buy
+300
New +$2.29K ﹤0.01% 3252

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Raymond James Financial Services Advisors's GHSI Position: Q1 2023 in Review

Raymond James Financial Services Advisors sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q1 2023, closing a stake of 300 shares — an estimated $2.18K sold.

Raymond James Financial Services Advisors first reported a position in GHSI in Q3 2022 and held it in 2 quarters. The position peaked at $2.18K in Q4 2022. 10 funds tracked by Wall St. Rank hold GHSI as of Q1 2023.

  • Raymond James Financial Services Advisors reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 300 Guardion Health Sciences, Inc. Common Stock shares in Q1 2023, an estimated $2.18K.
  • Raymond James Financial Services Advisors first reported a position in Guardion Health Sciences, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Raymond James Financial Services Advisors's Guardion Health Sciences, Inc. Common Stock position peaked at $2.18K in Q4 2022.
  • 10 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q1 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2023, filed 14 Apr 2023.